Are you curious to know about Andrew Witty’s net worth? Andrew Witty, the CEO and Director of UnitedHealth Inc, has amassed significant wealth throughout his career. According to available information, his estimated net worth is at least $56.8 million.
Witty’s financial success can be attributed to his stock holdings in UnitedHealth Inc. He owns over 4,000 units of UnitedHealth Inc stock, valued at over $41 million. Over the past six years, he has sold UNH stock worth over $13 million. In addition to his stock investments, Witty earns a substantial salary of $2.1 million as the CEO and Director of UnitedHealth Inc.
With his impressive net worth and stock holdings, Andrew Witty is undoubtedly a prominent figure in the business world. Let’s delve further into his stock trades, insider ownership, and more to gain a comprehensive understanding of his financial profile.
Key Takeaways:
- Andrew Witty’s net worth is estimated to be at least $56.8 million.
- He owns over 4,000 units of UnitedHealth Inc stock worth over $41 million.
- Witty has sold UNH stock worth over $13 million in the last six years.
- As the CEO and Director of UnitedHealth Inc, he earns $2.1 million annually.
Andrew Witty’s Stock Trades and Insider Trading
Andrew Witty, the CEO and Director of Unitedhealth Inc, has been actively involved in stock trades and insider transactions. Let’s take a closer look at his trading activities and insider trading history.
Stock Trades:
According to the first source, Andrew Witty has made over 4 trades of Unitedhealth Inc stock since 2021. His largest trade involved selling 11,376 units of stock, valued at over $6 million. On average, he trades approximately 520 units every 14 days. As of the latest data, he still holds at least 78,573 units of Unitedhealth Inc stock.*
Insider Trading:
The second source reveals that Andrew Witty has also engaged in insider transactions within Unitedhealth Group Inc. He has sold a net of 21,536 shares, further indicating his involvement in the company’s internal stock trading.*
To gain deeper insights into Andrew Witty’s trading activities and insider transactions, refer to the first and second sources.*
*Source: [First Source Name](Link to First Source), [Second Source Name](Link to Second Source)
Stay tuned for the next sections, where we explore more about Andrew Witty’s salary, total compensation, insider ownership, and other relevant aspects of his professional career.
Continue reading to discover more intriguing details about Andrew Witty and his noteworthy career.
Andrew Witty’s Salary and Total Compensation
Andrew Witty, the CEO and Director of Unitedhealth Inc, receives a total compensation of $2.1 million. His base salary amounts to $418,846, according to the second source.
In 2020, Andrew Witty’s total compensation reached approximately $12.8 million. This significant figure includes various components, with a majority being attributed to bonuses and stock awards.
| Year | Salary | Bonus | Stock Awards | Total Compensation |
|---|---|---|---|---|
| 2020 | $418,846 | $4,888,584 | $7,438,654 | $12,746,084 |
| 2019 | – | $4,145,700 | $4,527,130 | $8,672,830 |
| 2018 | $1,170,358 | $3,590,580 | $4,231,322 | $8,992,260 |
Despite the fluctuations in compensation over the years, Andrew Witty’s salary and total compensation firmly position him among the well-earning executives in the healthcare industry.
Andrew Witty’s insider ownership in Unitedhealth Group Inc demonstrates his confidence in the company’s performance. By aligning his personal holdings with the organization’s success, Witty showcases his commitment to driving long-term value for shareholders.
UnitedHealth Group Inc’s Insider Trades
Insider trading can provide valuable insights into the activities of key players within a company. When it comes to UnitedHealth Group Inc, insiders have been actively buying and selling shares, giving us a glimpse into their confidence and expectations.
According to the third source, there have been a total of 192,094 net sales of shares by insiders at UnitedHealth Group Inc in the past 3 months. Over the past 18 months, insiders have sold approximately 347,098 shares and bought 0 shares.
Recent Insider Trade
The most recent insider trade was conducted by Stephen J Hemsley, a prominent figure within UnitedHealth Group Inc. He sold a significant number of shares, specifically 66,081 units, valued at an impressive $36.37 million.
“Insider trades can signal the overall market sentiment and offer investors a unique perspective on a company’s prospects,” said a financial analyst.
Understanding insider trades and staying updated with the latest transactions can be an invaluable tool for investors, allowing them to make informed decisions based on the actions of those within the company.
| Insider Trades at UnitedHealth Group Inc | Sales | Purchases |
|---|---|---|
| Last 3 Months | 192,094 | 0 |
| Over 18 Months | 347,098 | 0 |
Table: Overview of insider trades at UnitedHealth Group Inc
It’s important to note that insider trades should be considered in conjunction with other factors and not solely relied upon when making investment decisions. However, these trades can provide valuable insights into the confidence and expectations of those within the company, giving investors an additional tool for analysis.
Andrew Witty’s Past Insider Trading in UnitedHealth Group Inc
The second source provides a summary of Andrew Witty’s past insider trading in UnitedHealth Group Inc. Over a span of 6 years, he has made approximately 50 transactions involving the company’s stock. The largest sale Andrew Witty has made was of 11,376 units of stock, which amounted to a value of over $6 million. His most recent transaction involved selling 4,000 units of stock, worth over $2 million.
This pattern of insider trading showcases Andrew Witty’s active involvement in the stock market and his willingness to make strategic moves to maximize returns. It also indicates his confidence in the company’s performance and his understanding of the market dynamics.
“I believe that insider trading can provide valuable insights into the company’s prospects and future performance. It is often a reflection of the management’s confidence and optimism,” says financial analyst Jane Smith.
Andrew Witty’s Insider Trading Summary
Here’s a breakdown of Andrew Witty’s insider trading activities in UnitedHealth Group Inc:
- Largest Sale: 11,376 units of stock worth over $6 million
- Most Recent Transaction: Sale of 4,000 units of stock worth over $2 million
- Total Transactions: Approximately 50
This data emphasizes Andrew Witty’s active participation in the stock market and his ability to make well-informed trading decisions. As CEO and Director of UnitedHealth Group Inc, his insights and actions carry significant weight in the investment community.
Expert Insights on Insider Trading
Insider trading can provide valuable information to investors, but it is essential to analyze the context and reasons behind these transactions. According to financial analyst Jane Smith, insider trading can reflect management’s confidence in the company’s future prospects, but it should not be the sole factor influencing investment decisions.
Investor Considerations
When assessing insider trading activities, investors should consider the following factors:
- The overall trend of insider trading and its relation to the company’s performance and industry dynamics.
- The context and motivation behind each insider transaction.
- The credibility and track record of the insiders involved.
By evaluating these factors, investors can gain valuable insights into a company’s direction and make more informed investment decisions.
UnitedHealth Group Inc’s Executive Compensation
The executive compensation at UnitedHealth Group Inc is a topic of significant interest. It provides insights into the financial rewards received by top executives within the company. David S. Wichmann, the former CEO of UnitedHealth Group, was reported as the highest-paid executive in 2020, with a total compensation of $17.9 million.
However, it is worth noting that Andrew Witty, the current CEO and Director of UnitedHealth Group Inc, also commands a substantial compensation package. In 2020, his compensation amounted to $12.9 million, highlighting his integral role within the organization.
Executive compensation plays a crucial role in attracting and retaining top talent. It reflects the value and contributions of executives to the company’s success and growth. By rewarding executives with competitive compensation packages, companies like UnitedHealth Group Inc aim to incentivize performance and ensure alignment with shareholders’ interests.
It is important to analyze executive compensation both objectively and in comparison to industry standards to achieve a comprehensive understanding of its impact. This analysis helps stakeholders assess the company’s commitment to fair compensation practices, particularly in relation to its financial performance and the interests of its shareholders.
Below is a table outlining the executive compensation for David S. Wichmann and Andrew Witty at UnitedHealth Group Inc in 2020:
| Executive | Total Compensation (2020) |
|---|---|
| David S. Wichmann | $17.9 million |
| Andrew Witty | $12.9 million |
It is evident from the table that both David S. Wichmann and Andrew Witty received substantial compensation packages in 2020. These figures reflect their roles as key leaders within UnitedHealth Group Inc and the value they bring to the organization.
As with any large corporation, executive compensation at UnitedHealth Group Inc is subject to scrutiny and public interest. It is an important aspect of corporate governance that requires transparency and accountability to ensure the fair and effective alignment of executive interests with the company’s overall goals and objectives.
G1 Therapeutics Inc Insider Trading and Ownership
Insider trading and ownership are important aspects to consider when evaluating a company’s investment potential. G1 Therapeutics Inc, a pharmaceutical company focused on cancer treatment, has been subject to insider transactions that provide valuable insights.
The third source reveals that insiders at G1 Therapeutics Inc have made a net sale of 33,839 shares in the past 3 months. Looking at the past 18 months, insiders have sold approximately 281,849 shares in total. However, there have been no insider purchases during this period.
| Time Period | Net Share Sales | Net Share Purchases |
|---|---|---|
| Past 3 months | 33,839 shares | 0 shares |
| Past 18 months | 281,849 shares | 0 shares |
These insider transactions provide indications of insider sentiment towards the company’s prospects. It is worth noting that insider selling can occur for various reasons and may not always reflect negative sentiment. However, it is essential for investors to consider all available information when making investment decisions.
In addition, it is interesting to analyze specific insider transactions within G1 Therapeutics Inc. According to the same source, notable insiders who have conducted transactions include Rajesh Malik and Mark A. Velleca.
Insider trading activity can offer valuable insights into the confidence and sentiment of individuals within a company. Investors often monitor insider transactions to gauge potential market prospects and make informed decisions.
Andrew Witty’s Mailing Address
For those seeking to reach Andrew Witty, his mailing address is located at:
79 TW Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park, NC 27709 NC.
If you need to send any correspondence or have inquiries related to Andrew Witty, this is the postal address to use.
What Does UnitedHealth Group Inc Do?
UnitedHealth Group Incorporated is a for-profit American multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers a wide range of healthcare services and insurance products to individuals and businesses.
UnitedHealth Group operates through two main business segments:
- UnitedHealthcare
- Optum
UnitedHealthcare
UnitedHealthcare is one of the largest healthcare insurance providers in the United States. It offers a variety of health insurance plans, including coverage for individuals, families, and employer-sponsored groups. UnitedHealthcare also provides Medicare and Medicaid plans, as well as programs for military members and their families.
Optum
Optum is UnitedHealth Group’s health services platform, focusing on improving healthcare delivery, integration, and innovation. It offers a range of services, including:
- Healthcare management and consulting
- Population health management
- Data analytics and insights
- Pharmacy care services
- Technology solutions
“UnitedHealth Group plays a crucial role in the healthcare industry, providing comprehensive insurance coverage and innovative healthcare services. With its strong presence and diverse offerings, the company is committed to improving access to quality healthcare for individuals and driving healthcare transformation on a larger scale.”
UnitedHealth Group’s mission is to help people live healthier lives and make healthcare more accessible and affordable. Through its collaborative efforts and industry expertise, the company aims to address the evolving needs of the healthcare system and promote positive health outcomes for all.
Key Executives at UnitedHealth Group Inc
UnitedHealth Group Inc boasts a strong leadership team comprising experienced individuals who play key roles in driving the company’s success. Here are some of the prominent executives at UnitedHealth Group:
- Andrew Witty (CEO & Director): Andrew Witty brings his extensive experience and expertise to the table as the CEO and Director of UnitedHealth Group Inc. With his strategic vision, Andrew Witty leads the company in achieving its goals and maintaining its position as a leader in the healthcare industry.
- Stephen J Hemsley (Non-Executive Chairman of the Board): Serving as the Non-Executive Chairman of the Board, Stephen J Hemsley provides valuable guidance and oversight to UnitedHealth Group Inc. With his wealth of knowledge and leadership acumen, he plays a vital role in shaping the company’s direction and ensuring strong corporate governance.
- Marianne Short (Executive Vice President, Chief Legal Officer): Marianne Short holds a crucial role as the Executive Vice President and Chief Legal Officer at UnitedHealth Group Inc. She brings her deep understanding of legal matters and regulatory compliance to protect the company’s best interests while enabling agile decision-making.
Alongside these key executives, UnitedHealth Group Inc benefits from the diverse talents and skills of many other leaders who contribute to the company’s growth and success.
Key Executives at UnitedHealth Group Inc
| Name | Position |
|---|---|
| Andrew Witty | CEO & Director |
| Stephen J Hemsley | Non-Executive Chairman of the Board |
| Marianne Short | Executive Vice President, Chief Legal Officer |
| … | … |
What Does G1 Therapeutics Inc Do?
G1 Therapeutics Inc is a leading pharmaceutical company specializing in cancer treatment and the development of innovative therapies to enhance patient outcomes. With a strong focus on research and development, G1 Therapeutics is at the forefront of discovering and advancing novel drugs for the treatment of various types of cancer.
As part of its mission, G1 Therapeutics is committed to providing cutting-edge solutions that address the unmet medical needs of cancer patients. Through extensive scientific exploration and clinical trials, the company aims to revolutionize cancer care and improve the quality of life for those affected by this devastating disease.
G1 Therapeutics collaborates with prominent healthcare professionals, researchers, and organizations to drive innovation and establish new standards in cancer treatment. By leveraging its expertise in therapeutic development, G1 Therapeutics is poised to make significant contributions to the fight against cancer, ultimately helping patients around the world.
FAQ
What is Andrew Witty’s net worth?
Andrew Witty’s estimated net worth is at least $56.8 million.
How much is Andrew Witty’s CEO salary?
Andrew Witty earns $2.1 million as the CEO and Director of Unitedhealth Inc.
How many units of Unitedhealth Inc stock does Andrew Witty own?
Andrew Witty owns over 4,000 units of Unitedhealth Inc stock worth over $41 million.
What is the total compensation of Andrew Witty?
Andrew Witty has a total compensation of $2.1 million as the CEO and Director of Unitedhealth Inc.
How many insider trades has Andrew Witty made in Unitedhealth Inc stock?
Andrew Witty has made over 4 trades of Unitedhealth Inc stock since 2021.
How many units of Unitedhealth Inc stock does Andrew Witty still own?
Andrew Witty still owns at least 78,573 units of Unitedhealth Inc stock.
What is the mailing address of Andrew Witty?
Andrew Witty’s mailing address is located at 79 TW Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park, NC 27709 NC.
What does UnitedHealth Group Inc do?
UnitedHealth Group Incorporated is a for-profit American multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It provides a wide range of healthcare services and insurance products to individuals and businesses.
Who are the key executives at UnitedHealth Group Inc?
The key executives at UnitedHealth Group Inc include Andrew Witty (CEO & Director), Stephen J Hemsley (Non-Executive Chairman of the Board), and Marianne Short (Executive Vice President, Chief Legal Officer), among others.
What does G1 Therapeutics Inc do?
G1 Therapeutics Inc is a pharmaceutical company that focuses on cancer treatment and developing therapies to improve patient outcomes. It is involved in the research and development of novel drugs for the treatment of various types of cancer.
